| Literature DB >> 12138019 |
Mauro A M Carai1, Roberta Agabio, Carla Lobina, Roberta Reali, Giovanni Vacca, Giancarlo Colombo, Gian Luigi Gessa.
Abstract
The effect of acutely administered gamma-hydroxybutyric acid (GHB) and GHB receptor antagonist, NCS-382, on the propulsive activity in the mouse small intestine was assessed by measuring the transit of an orally administered, non absorbable marker. Both GHB (0, 25, 50, 100, 200 and 300 mg/kg; i.p.) and NCS-382 (0, 25, 50 and 75 mg/kg; i.p.) induced a dose-dependent inhibition (up to 50-60%) of the marker transit. Pretreatment with the GABA(B) receptor antagonist, SCH 50911 (100 mg/kg; i.p.), resulted in the blockade of the inhibiting effect of both GHB and NCS-382. These results suggest that the constipating effect of GHB and NCS-382 are secondary to stimulation of the GABA(B) receptor.Entities:
Mesh：
Substances：
Year: 2002 PMID： 12138019 DOI： 10.1016/s0024-3205(02)01553-9
Source DB: PubMed Journal: Life Sci ISSN： 0024-3205 Impact factor: 5.037